Hsbc Holdings PLC purchased a new stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 76,254 shares of the company's stock, valued at approximately $4,818,000.
A number of other hedge funds have also modified their holdings of NTR. Montag A & Associates Inc. lifted its holdings in shares of Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company's stock worth $26,000 after purchasing an additional 320 shares during the period. Thurston Springer Miller Herd & Titak Inc. increased its holdings in Nutrien by 1,014.0% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 479 shares of the company's stock worth $30,000 after buying an additional 436 shares during the period. Global Retirement Partners LLC acquired a new position in Nutrien in the 2nd quarter worth approximately $30,000. Evolution Wealth Management Inc. purchased a new position in Nutrien during the 1st quarter worth approximately $32,000. Finally, Allied Private Wealth LLC purchased a new position in Nutrien during the 2nd quarter worth approximately $33,000. 63.10% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
NTR has been the topic of several recent research reports. Raymond James Financial raised shares of Nutrien from a "market perform" rating to an "outperform" rating and upped their price objective for the company from $74.00 to $90.00 in a report on Tuesday, May 5th. Berenberg Bank set a $65.00 target price on shares of Nutrien and gave the company a "hold" rating in a research report on Wednesday, June 10th. National Bank Financial lowered their price target on shares of Nutrien from $76.00 to $74.00 and set an "outperform" rating on the stock in a report on Monday, August 10th. BNP Paribas Exane raised Nutrien from a "neutral" rating to an "outperform" rating and set a $80.00 price target on the stock in a research report on Tuesday, July 28th. Finally, Wall Street Zen lowered Nutrien from a "buy" rating to a "hold" rating in a research note on Saturday, May 16th. Seventeen research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $81.58.
Check Out Our Latest Analysis on NTR
Key Nutrien News
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
- Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
- Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
- Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.
Nutrien Stock Performance
NTR opened at $73.64 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.39 and a quick ratio of 0.86. The firm has a fifty day moving average price of $67.33 and a 200 day moving average price of $70.56. Nutrien Ltd. has a 1 year low of $53.03 and a 1 year high of $85.36. The stock has a market cap of $35.23 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.78 and a beta of 0.61.
Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The firm had revenue of $10.81 billion for the quarter, compared to analyst estimates of $10.44 billion. During the same quarter in the prior year, the business posted $2.65 EPS. The firm's quarterly revenue was up 3.6% compared to the same quarter last year. Equities research analysts anticipate that Nutrien Ltd. will post 4.71 earnings per share for the current year.
Nutrien Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be given a dividend of $0.55 per share. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.0%. Nutrien's dividend payout ratio (DPR) is 44.53%.
About Nutrien
(
Free Report)
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
